As India's largest COVID-19 vaccination drive begins, an AIIMS professor claims that the latest trials show that the safety and…
“We are going to start trial for nasal vaccine very soon and I believe it might be a game changer…
The benefits of a WHO approval for Bharat Biotech's Covid-19 vaccine, dubbed Covaxin, include easier international travel for Indians and…
The booster dose is being given six months after the trial participant received the second dose of the vaccine. The…
Bharat Biotech is likely to get approval from the World Health Organization in two weeks for the emergency use listing…
Mansukh Mandaviya, Union Health Minister, inaugurated the first commercial batch of Covaxin on Sunday from Bharat Biotech's new factory in…
The Union ministry of science announced on Friday that Bharat Biotech has received authorisation from India's pharma regulator to undertake…
According to a research published in the biorxiv by the Indian Council of Medical and Research (ICMR), Bharat Biotech's Covid-19…
India achieved the target of 47 crore COVID-19 vaccine doses till the month of July, Dr N K Arora, Chief…
Rotavac 5D, a variation of Bharat Biotech International Limited's Rotavac vaccine, got "Prequalification" from the World Health Organization (WHO) on…